Overview
Theileriosis, caused by parasites of the genus Theileria, significantly impacts ruminants, leading to substantial economic losses in livestock. Current live attenuated vaccines face limitations, prompting exploration into novel vaccine designs such as mRNA vaccines targeting the parasite's proteome 1.Diagnosis
Detection of specific IgM and IgG antibodies from 18 to 36 days post-infection, persisting up to 120 days 3.
Utilization of monoclonal antibodies specific to Theileria parva surface coat antigens for stage-specific identification, particularly noting the absence of these antigens in non-sporozoite stages 2.Management
No specific first-line treatments mentioned in the abstracts; management likely focuses on supportive care and control measures 123.
Exploration of novel vaccine approaches, such as mRNA vaccines targeting key parasite antigens, as adjunctive preventive strategies 1.Special Populations
No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the context of Theileria infection 123.Key Recommendations
Prioritize the development and evaluation of mRNA vaccines targeting Theileria surface antigens for enhanced vaccine efficacy (Evidence: Expert opinion) 1.
Monitor and detect specific IgM and IgG antibodies for diagnostic purposes and disease progression tracking in cattle (Evidence: Moderate) 3.
Consider stage-specific antigenic markers for diagnostic tools, focusing on sporozoite stages due to their unique surface antigens (Evidence: Moderate) 2.References
1 Fattahi R, Sadeghi Kalani B. mRNA vaccine design using the proteome of . mSphere 2025. link
2 Dobbelaere DA, Webster P, Leitch BL, Voigt WP, Irvin AD. Theileria parva: expression of a sporozoite surface coat antigen. Experimental parasitology 1985. link80026-6)
3 Goldman M, Pipano E. Specific IgM and IgGAntibodies in cattle immunized or infected with Theileria annulata. Tropenmedizin und Parasitologie 1978. link